| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Laura I. Bushnell last filed a Form 4 in May 2024, as Director at VINC. Laura I. Bushnell's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 19,202 shares of VINC. Net of sales, the VINC filings show accumulation of 19,202 shares.
Laura I. Bushnell has 8 Form 4 filings on record from December 2020 to May 2024, all as Director at Vincerx Pharma (VINC), 2020–2024.
The 8 reported transactions were 5 option or other derivative awards and 3 open-market purchases.
Counted by filing, the open-market trades come to 3 purchases worth about $77K and no sales.
The largest open-market purchase was 15,000 shares of VINC at an average $1.91 on June 9, 2022, about $29K.
Shares as reported in the last Form 4 for each company; the most recent is from May 2024. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.